Posted inHealthcare

Lawmakers Must Fix Medicare’s Drug Price Distortions

Mehmet Oz recently took the reins as the new head of the Centers for Medicare & Medicaid Services (CMS), which oversees health coverage for nearly half of Americans. He will be responsible for overseeing the drug-price negotiations with the agency’s pharmaceutical manufacturers. The goal of these negotiations, created by the 2022 Inflation Reduction Act, is to reduce […]